Zevra Therapeutics Inc (ZVRA)

EBITDA

$13.16M

Quarterly · Period ending: · USD

ZVRA logo

ZVRA EBITDA

Latest reported$13.16M
ZVRA Quarterly EBITDA (-$1.18M → $13.16M)
High-resolution chart · PNG

ZVRA ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Zevra Therapeutics Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
13,158,000
43,461,000
14,976,000
1,466,000
80,566,000
1,701,000
-16,526,000
-29,296,000
-16,183,000
-14,395,000
-13,610,000
-13,440,000
-2,372,000
-13,059,000
-8,737,000
-6,127,000
-24,540,000
-1,798,000
-2,600,000
-1,688,000
6,292,000
-9,883,000
-3,178,000
-1,235,000
2,698,000
-3,628,000
-4,106,000
3,310,000
-7,654,000
-10,687,000
-3,370,000
-13,359,000
-8,140,000
-24,312,000
-8,678,000
-8,059,000
-4,604,000
-14,415,000
-8,041,000
-11,560,000
-9,246,000
-1,304,000
-8,008,000
-8,537,000
-28,592,000
-4,838,000
-7,468,264
-6,507,000
-2,696,000
-1,795,000
-1,179,423
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.